These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3823028)

  • 1. [Evaluation of the metabolizing function of the liver in thyrotoxicosis using the antipyrine test].
    Salakhova NS; Nazhmutdinova DK
    Probl Endokrinol (Mosk); 1987; 33(1):9-11. PubMed ID: 3823028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine and doxycycline pharmacokinetics in patients with thyroid disorders.
    Nayak VK; Desai NK; Kshirsagar NA; Bhandarkar SD; Satoskar RS
    J Postgrad Med; 1991 Jan; 37(1):5-8. PubMed ID: 1941694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of the antipyrine test in assessing liver function in patients with insulin-dependent diabetes mellitus].
    Khanina EV; Gorshteĭn ES; Michurina SP
    Probl Endokrinol (Mosk); 1990; 36(3):14-5. PubMed ID: 2395825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A; Lowicki Z; Chmara E; Mrozikiewicz A; Baczyk K
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):339-41. PubMed ID: 2235722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipyrine test in evaluation of the functional state of the liver in the postoperative period].
    Nadzhimutdinov KN; Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Kaiumov TKh
    Khirurgiia (Mosk); 1986 Feb; (2):21-3. PubMed ID: 3959450
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipyrine kinetics in liver disease and liver transplantation.
    Mehta MU; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Yang SL; Gray JA; Van Thiel DH; Starzl TE
    Clin Pharmacol Ther; 1986 Apr; 39(4):372-7. PubMed ID: 3514052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mono-oxygenase enzyme system of the liver in patients with true eczema].
    Ashirmetov AKh; Akovbian VA; Krakovskiĭ ME; Tikhonova NN
    Vestn Dermatol Venerol; 1990; (4):46-9. PubMed ID: 2143879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of ACTH and hydrocortisone on drug kinetics in calves in the example of the antipyrine test].
    Janus K; Jakubowska D; Jankowiak D; Skrzypczak WF
    Pol Arch Weter; 1991; 31(1-2):25-31. PubMed ID: 1668210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detoxification function of the liver and body resistance in patients with acute intestinal obstruction].
    Razzakov SM; Krakovskiĭ ME; Ashirmetov AKh
    Khirurgiia (Mosk); 1990 Dec; (12):11-5. PubMed ID: 2079783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].
    Uhlig H; Damrau J; Skölziger R
    Z Gesamte Hyg; 1989 Feb; 35(2):82-4. PubMed ID: 2741499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of thyrotoxicosis on isoniazid acetylation.
    Littley MD; Hutchings A; Spragg BP; Routledge PA; Lazarus JH
    Br J Clin Pharmacol; 1988 Jul; 26(1):103-6. PubMed ID: 2462441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.